Treating 5 percent of hepatitis C patients with new drugs would reduce cost and infections, study shows
Treating 5 percent of all hepatitis C patients with the latest drugs would be more effective at reducing infections and health care costs than the current approach, a new study shows.
Oct 7, 2015
0
26